Prokidney (PROK) Revenue (2024 - 2026)
Prokidney (PROK) reported Revenue of $226000.0 for Q1 2026, down 1.74% year-over-year from $230000.0 in Q1 2025, and little changed on a QoQ basis from $225000.0 in Q4 2025.
Prokidney (PROK) has 3 years of Revenue data on file, last reported at $226000.0 in Q1 2026.
- Quarterly Revenue fell 1.74% year-over-year to $226000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $889000.0 (up 190.52% YoY) and the FY2025 annual result came in at $893000.0, up 1075.0% from the prior year.
- Revenue held at $226000.0 in Q1 2026 per PROK's latest filing, from $225000.0 in the prior quarter.
- Across five years, Revenue topped out at $230000.0 in Q1 2025 and bottomed at $76000.0 in Q4 2024.
- The 3-year median for Revenue is $223000.0 (2025), against an average of $199166.7.
- The widest annual swing landed in 2025, when Revenue soared 196.05%; it then declined 1.74% in 2026.
- Tracing PROK's Revenue over 3 years: stood at $76000.0 in 2024, then surged by 196.05% to $225000.0 in 2025, then gained by 0.44% to $226000.0 in 2026.
- Per Business Quant, the three latest PROK Revenue figures stand at $226000.0 (Q1 2026), $225000.0 (Q4 2025), and $217000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 306.30 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 2.99 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.61 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.17 Bn |
| 10 | Prokidney | 259.72 Mn | 1.55 Bn | - | 226,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 226,000.00 |
| Dec 31, 2025 | 225,000.00 |
| Sep 30, 2025 | 217,000.00 |
| Jun 30, 2025 | 221,000.00 |
| Mar 31, 2025 | 230,000.00 |
| Dec 31, 2024 | 76,000.00 |